Search, personalize, or simply browse. Follow the world around you from gist and context to insights.
Who we are | Our Credo | Ways of using Lyrarc | FAQ | Send Feedback | First Letter From the Editor
Sign up. It's free and easy to use
Create an account
to personalize your feed of articles and topics.
Keywords:
Tags:
With growing demand for low cost affordable drugs the growth in sales of generics.
Grouped Articles
Indian Drug Maker Vies for Betapharm
Wall Street Journal 02/09/2006
Branded Drugs Settling More Generic Suits
Wall Street Journal 01/17/2006
Generics Eat Into Pfizer's Profit; Costs Offset Novartis Sales Gain
Wall Street Journal 01/20/2006
As Generics Pummel Its Drugs, Pfizer Faces Uncertain Future
Wall Street Journal 01/05/2006
Teva to Acquire Ivax, Another Maker of Generic Drugs
New York Times 07/26/2005
Wall Street Journal 07/26/2005
The rapidly growing Indian pharmaceutical companies. The Indian market $8 billion today will grow to $30 billion in the next 10 years as more people get access to better healthcare. Sales in the Middle East, Africa and Latin America, and outsourcing manufacture for western companies are additional sources of growth for these companies.
Grouped Articles
Looking East, Big Pharma Cuts Prices
BusinessWeek 04/15/2010
India Administers Price-Cap Dose to Drug Companies
Wall Street Journal 09/22/2014
Indian Drug Maker Vies for Betapharm
Wall Street Journal 02/09/2006
Economist 11/08/2007
India's Drug Firms May Boost a Healthy Portfolio
Wall Street Journal 12/17/2007
Indian Companies Hit Their Stride
BusinessWeek 09/17/2007
FDA's efforts to ensure safety by inspecting facilities.
Grouped Articles
China Worries Could Hurt Pharma’s Health
Wall Street Journal 08/24/2015
China Sentences Former Drug Regulator to Death
New York Times 05/29/2007
China Faces a New Worry: Heavy Metals in the Food
Wall Street Journal 07/02/2007
China-Product Scare Hits Home, Too
Wall Street Journal 07/20/2007
India's Drug Firms May Boost a Healthy Portfolio
Wall Street Journal 12/17/2007
BusinessWeek 09/04/2008
Grouped Articles
Wall Street Journal 12/01/2007
BusinessWeek 09/04/2008
Pfizer Profit Declines 19% After Loss of Lipitor Patent
New York Times 05/01/2012
Novartis' CEO Vasella, and Dr Fishman who heads the global research labs in Cambridge, Massachusetts, are redoing the way the company develops drugs and runs the company. Senior leaders are now medically trained scientists, and Novartis has shed much of the old marketing and sales staff. Drug discovery focusses on Dr. Fishman's approach to go after common molecular pathways and develop medicines for diseases that may be rare, but reveal the knowledge behind addressing all diseases that have that common underlying molecular pathway as the source of the diseases functioning.
Grouped Articles
Novartis Chairman Stresses Need for R&D Investment
Wall Street Journal 03/22/2014
Wall Street Journal 12/11/2007
Wall Street Journal 12/17/2007
BusinessWeek 05/08/2008
CEO Gambles on a Novartis Makeover
Wall Street Journal 05/20/2008
BusinessWeek 09/04/2008
Training more personnel for pharmaceutical testing and trials, building other knowhow for generating credible data, building partnerships with WHO and FDA, and ensuring the safety of patients, is being taken up by the Indian government and pharmaceutical industry to develop this opportunity.
Grouped Articles
The Rush To Test Drugs In China
BusinessWeek 05/28/2007
BusinessWeek 09/04/2008
New Concern for Drug Tests Abroad
Wall Street Journal 03/23/2009
India’s drug trials fuel controversy - The Washington Post
Washington Post 01/02/2012
Grouped Articles
Indian Drugmakers Target Niche Markets
Wall Street Journal 04/19/2016
In Trade Deal, a Shift on Generics
Wall Street Journal 05/17/2007
Economist 11/08/2007
India's Drug Firms May Boost a Healthy Portfolio
Wall Street Journal 12/17/2007
Indian Companies Hit Their Stride
BusinessWeek 09/17/2007
BusinessWeek 09/04/2008
We took a different way to help millions around the world build educated informed mindsets that affects and shapes their lives. For a future that is open, global and digital, with everyone having access to high quality information. We believe in the renewal of America, renewal of Europe, the renewal of India, the rest of Asia, Latin America and Africa. The renewal of our supply chains, health, education, infrastructure, as we rebuild our countries after the pandemic. Literacy and knowledge we believe cannot thrive and grow in a world of web bots, web crawlers, or AI. This requires human curiosity, human learning, and human imagination. We take as inspiration the saying- “One has to be free, and as broad as sky. One has to have a mind that is crystal clear, only then can truth shine in it.” Every contribution whether big or small is precious- in this crisis and ahead.
Support Lyrarc from as small as $1